المؤلفون: Pun PH; Duke Clinical Research Institute, Durham, NC, USA Department of Medicine, Duke University Medical Center, Durham, NC, USA., Hellkamp AS; Duke Clinical Research Institute, Durham, NC, USA., Sanders GD; Duke Clinical Research Institute, Durham, NC, USA., Middleton JP; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Hammill SC; Mayo Clinic, Rochester, MN, USA., Al-Khalidi HR; Duke Clinical Research Institute, Durham, NC, USA., Curtis LH; Duke Clinical Research Institute, Durham, NC, USA., Fonarow GC; Ahmason-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, CA, USA., Al-Khatib SM; Duke Clinical Research Institute, Durham, NC, USA Department of Medicine, Duke University Medical Center, Durham, NC, USA.

المصدر: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2015 May; Vol. 30 (5), pp. 829-35. Date of Electronic Publication: 2014 Nov 17.

نوع المنشور: Comparative Study; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8706402 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2385 (Electronic) Linking ISSN: 09310509 NLM ISO Abbreviation: Nephrol Dial Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable*, Death, Sudden, Cardiac/*prevention & control , Heart Failure/*complications , Kidney Failure, Chronic/*complications , Renal Dialysis/*methods, Aged ; Aged, 80 and over ; Death, Sudden, Cardiac/epidemiology ; Female ; Heart Failure/mortality ; Humans ; Incidence ; Kidney Failure, Chronic/mortality ; Male ; Middle Aged ; Primary Prevention ; Propensity Score ; Proportional Hazards Models ; Registries ; Retrospective Studies

المؤلفون: Pokorney SD; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Hellkamp AS; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Yancy CW; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Curtis LH; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Hammill SC; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Peterson ED; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Masoudi FA; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Bhatt DL; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Al-Khalidi HR; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Heidenreich PA; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Anstrom KJ; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Fonarow GC; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.)., Al-Khatib SM; From the Division of Cardiology, Duke University Medical Center (S.D.P., E.D.P., S.M.A.-K.), Duke Clinical Research Institute (S.D.P., A.S.H., L.H.C., E.D.P., H.R.A.-K., K.J.A., S.M.A.-K.), Durham, NC; Division of Cardiology, Northwestern University Medical Center, Chicago, IL (C.W.Y.); Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Denver (F.A.M.); Division of Cardiology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA (D.L.B.); Division of Cardiology, Stanford University, Palo Alto, CA (P.A.H.); and Division of Cardiology, UCLA Health System, Los Angeles, CA (G.C.F.). alkha001@mc.duke.edu.

المصدر: Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2015 Feb; Vol. 8 (1), pp. 145-51. Date of Electronic Publication: 2014 Dec 12.

نوع المنشور: Comparative Study; Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101474365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-3084 (Electronic) Linking ISSN: 19413084 NLM ISO Abbreviation: Circ Arrhythm Electrophysiol Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable* , Ethnicity* , Minority Groups* , Racial Groups*, Death, Sudden, Cardiac/*prevention & control , Electric Countershock/*instrumentation , Healthcare Disparities/*ethnology , Primary Prevention/*instrumentation, Age Factors ; Aged ; Aged, 80 and over ; Comparative Effectiveness Research ; Death, Sudden, Cardiac/ethnology ; Electric Countershock/adverse effects ; Electric Countershock/mortality ; Humans ; Medicare ; Primary Prevention/methods ; Registries ; Risk Factors ; Time Factors ; Treatment Outcome ; United States/epidemiology

المؤلفون: Zeitler EP; Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Hellkamp AS; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California., Hammill SC; Mayo Clinic, Rochester, Minnesota., Curtis LH; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Hernandez AF; Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Al-Khalidi HR; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Curtis JP; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut., Heidenreich PA; VA Palo Alto Health Care System, Palo Alto, California., Anstrom KJ; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Peterson ED; Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Mark DB; Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Hammill BG; Duke Clinical Research Institute, Durham, North Carolina., Sanders GD; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina., Al-Khatib SM; Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Department of Medicine, Division of Cardiology, Durham, North Carolina. Electronic address: alkha001@mc.duke.edu.

المصدر: JACC. Heart failure [JACC Heart Fail] 2015 Feb; Vol. 3 (2), pp. 159-67. Date of Electronic Publication: 2014 Nov 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable*, Heart Failure/*mortality , Heart Failure/*therapy , Ventricular Dysfunction, Left/*mortality , Ventricular Dysfunction, Left/*therapy, Adrenergic beta-Antagonists/therapeutic use ; Aged ; Aged, 80 and over ; Angiotensin Receptor Antagonists/therapeutic use ; Female ; Humans ; Male ; Primary Prevention ; Propensity Score ; Registries ; United States/epidemiology

المؤلفون: Hess PL; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.). p.hess@duke.edu., Hellkamp AS; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Peterson ED; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Sanders GD; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Al-Khalidi HR; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Curtis LH; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Hammill BG; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Pun PH; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Curtis JP; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Anstrom KJ; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Hammill SC; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.)., Al-Khatib SM; From the Duke Clinical Research Institute, Durham, NC (P.L.H., A.S.H., E.D.P., G.D.S., H.R.A.-K., L.H.C., B.G.H., P.H.P., K.J.A., S.M.A.-K.); Department of Medicine, Duke University Medical Center, Durham, NC (P.L.H., A.S.H., E.D.P., P.H.P., S.M.A.-K.); Department of Medicine, Yale University, New Haven, CT (J.P.C.); and Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN (S.C.H.).

المصدر: Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2014 Oct; Vol. 7 (5), pp. 793-9. Date of Electronic Publication: 2014 Jul 18.

نوع المنشور: Journal Article; Observational Study; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101474365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-3084 (Electronic) Linking ISSN: 19413084 NLM ISO Abbreviation: Circ Arrhythm Electrophysiol Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable*, Death, Sudden, Cardiac/*prevention & control , Electric Countershock/*instrumentation , Electric Countershock/*mortality , Heart Failure/*mortality , Heart Failure/*therapy , Primary Prevention/*instrumentation , Renal Insufficiency, Chronic/*mortality, Aged ; Cause of Death ; Chi-Square Distribution ; Comorbidity ; Electric Countershock/adverse effects ; Female ; Glomerular Filtration Rate ; Heart Failure/diagnosis ; Humans ; Kaplan-Meier Estimate ; Kidney/physiopathology ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Patient Selection ; Proportional Hazards Models ; Prosthesis Design ; Registries ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/physiopathology ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Time Factors ; Treatment Outcome ; United States/epidemiology

المؤلفون: Al-Khatib SM; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina3Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Hellkamp AS; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Fonarow GC; Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California., Mark DB; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina3Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Curtis LH; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina2Center for Clinical and Genetic Economics, Department of Medicine, Duke University Medical Center, Durham, North Carolina4Division of General., Hernandez AF; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina3Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Anstrom KJ; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Peterson ED; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina3Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Sanders GD; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Al-Khalidi HR; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Hammill BG; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina., Heidenreich PA; Stanford University, Palo Alto Veteran's Health Care System, Palo Alto, California., Hammill SC; Duke Clinical Research Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina2Center for Clinical and Genetic Economics, Department of Medicine, Duke University Medical Center, Durham, North Carolina7Mayo Clinic, Rochest.

المصدر: JAMA [JAMA] 2014 Jun 04; Vol. 311 (21), pp. 2209-15.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable* , Ventricular Dysfunction, Left*, Heart Failure/*therapy, Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Heart Failure/mortality ; Humans ; Male ; Medicare/statistics & numerical data ; Propensity Score ; Registries ; Retrospective Studies ; Risk ; Survival Analysis ; United States ; Ventricular Function, Left

المؤلفون: Al-Khatib SM; MHS, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA. alkha001@mc.duke.edu, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, Heidenreich PA, Hammill S, Yancy C, Peterson ED

مؤلفون مشاركون: Get With the Guidelines Steering Committee and Hospitals

المصدر: Circulation [Circulation] 2012 Mar 06; Vol. 125 (9), pp. 1094-101. Date of Electronic Publication: 2012 Jan 27.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable*/statistics & numerical data , Defibrillators, Implantable*/trends , Healthcare Disparities*/ethnology , Healthcare Disparities*/statistics & numerical data , Healthcare Disparities*/trends, Black People/*statistics & numerical data , Heart Failure/*ethnology , Heart Failure/*therapy, Aged ; Aged, 80 and over ; Databases, Factual/statistics & numerical data ; Female ; Humans ; Inpatients/statistics & numerical data ; Male ; Risk Factors ; Sex Distribution ; United States/epidemiology ; White People/statistics & numerical data

المؤلفون: Dorian P; Division of Cardiology, St. Michael's Hospital/University of Toronto, Toronto, Ontario, Canada. dorianp@smh.toronto.on.ca, Al-Khalidi HR, Hohnloser SH, Brum JM, Dunnmon PM, Pratt CM, Holroyde MJ, Kowey P

مؤلفون مشاركون: Shock Inhibition Evaluation with Azimilide Investigators

المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2008 Sep 23; Vol. 52 (13), pp. 1076-83.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable*, Anti-Arrhythmia Agents/*administration & dosage , Arrhythmias, Cardiac/*prevention & control , Imidazolidines/*administration & dosage , Piperazines/*administration & dosage, Aged ; Anti-Arrhythmia Agents/adverse effects ; Emergency Service, Hospital ; Hospitalization ; Humans ; Hydantoins ; Imidazolidines/adverse effects ; Middle Aged ; Piperazines/adverse effects

المؤلفون: Hohnloser SH; Division of Electrophysiology, Department of Cardiology, J.W. Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. hohnloser@em.uni-frankfurt.de, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, Tchou P, Dorian P

مؤلفون مشاركون: SHock Inhibition Evaluation with AzimiLiDe (SHIELD) Investigators

المصدر: European heart journal [Eur Heart J] 2006 Dec; Vol. 27 (24), pp. 3027-32. Date of Electronic Publication: 2006 Oct 18.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0195-668X (Print) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable*, Anti-Arrhythmia Agents/*therapeutic use , Calcium Channel Blockers/*therapeutic use , Imidazolidines/*therapeutic use , Piperazines/*therapeutic use , Tachycardia, Ventricular/*therapy, Cohort Studies ; Female ; Humans ; Hydantoins ; Male ; Middle Aged ; Prospective Studies ; Tachycardia, Ventricular/prevention & control ; Treatment Outcome

المؤلفون: Pratt CM; The Methodist DeBakey Heart Center and the Section of Cardiology, Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA. cpratt@bcm.tmc.edu, Dorian P, Al-Khalidi HR, Brum JM, Borggrefe M, Tatla DS, Brachmann J, Myerburg RJ, Cannom DS, Holroyde MJ, van der Laan M, Hohnloser SH

مؤلفون مشاركون: SHIELD Investigators

المصدر: The American journal of cardiology [Am J Cardiol] 2005 Jan 15; Vol. 95 (2), pp. 274-6.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0207277 Publication Model: Print Cited Medium: Print ISSN: 0002-9149 (Print) Linking ISSN: 00029149 NLM ISO Abbreviation: Am J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Defibrillators, Implantable* , Randomized Controlled Trials as Topic*, Anti-Arrhythmia Agents/*administration & dosage , Imidazolidines/*administration & dosage , Piperazines/*administration & dosage , Tachycardia, Ventricular/*therapy, Double-Blind Method ; Drug Administration Schedule ; Humans ; Hydantoins ; Research Design ; Tachycardia, Ventricular/drug therapy ; Treatment Outcome